Interferon alpha-2b human recombinant - Pharmaclon

Drug Profile

Interferon alpha-2b human recombinant - Pharmaclon

Alternative Names: Alfarona; Alpharona

Latest Information Update: 10 Aug 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Pharmaclon
  • Class Antineoplastics; Antivirals; Interferons
  • Mechanism of Action Immunomodulators; Interferon alpha stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Acute lymphoblastic leukaemia; Basal cell cancer; Chronic myeloid leukaemia; Conjunctivitis; Hairy cell leukaemia; Hepatitis B; Hepatitis C; Hepatitis D; Lymphoma; Multiple sclerosis; Mycoplasma infections; Recurrent respiratory papillomatosis; Renal cancer; Squamous cell cancer; Thrombocytopenia

Most Recent Events

  • 17 Apr 2016 Biomarkers information updated
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top